Citigroup Inc. Has $238,000 Stock Holdings in Enhabit, Inc. (NYSE:EHAB)

Citigroup Inc. lessened its holdings in Enhabit, Inc. (NYSE:EHAB) by 43.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 21,158 shares of the company’s stock after selling 16,446 shares during the quarter. Citigroup Inc.’s holdings in Enhabit were worth $238,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of EHAB. Northern Trust Corp acquired a new stake in shares of Enhabit in the 2nd quarter valued at $494,000. Millennium Management LLC acquired a new stake in shares of Enhabit in the 2nd quarter valued at $230,000. UBS Group AG boosted its holdings in shares of Enhabit by 407,300.0% in the 3rd quarter. UBS Group AG now owns 12,222 shares of the company’s stock valued at $171,000 after purchasing an additional 12,219 shares in the last quarter. Dimensional Fund Advisors LP acquired a new stake in shares of Enhabit in the 3rd quarter valued at $9,662,000. Finally, Credit Suisse AG acquired a new stake in shares of Enhabit in the 3rd quarter valued at $686,000.

Enhabit Stock Up 2.0 %

Shares of NYSE:EHAB opened at $11.57 on Thursday. The firm has a market cap of $580.35 million, a P/E ratio of -7.14, a P/E/G ratio of 1.70 and a beta of 1.86. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.76. Enhabit, Inc. has a 12-month low of $7.12 and a 12-month high of $14.59. The business has a fifty day simple moving average of $9.95 and a 200 day simple moving average of $9.99.

Enhabit (NYSE:EHAB) last announced its earnings results on Wednesday, March 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.01. The business had revenue of $260.60 million during the quarter, compared to analyst estimates of $260.30 million. Enhabit had a positive return on equity of 1.55% and a negative net margin of 7.69%. During the same period last year, the company earned $0.32 EPS. Analysts predict that Enhabit, Inc. will post 0.24 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts recently weighed in on EHAB shares. TD Cowen started coverage on Enhabit in a report on Tuesday, December 12th. They set a “market perform” rating and a $12.00 price objective on the stock. UBS Group raised Enhabit from a “sell” rating to a “neutral” rating and set a $9.50 price objective on the stock in a report on Thursday, March 7th. Oppenheimer reissued a “market perform” rating on shares of Enhabit in a report on Thursday, March 7th. Finally, Jefferies Financial Group cut their price objective on Enhabit from $15.00 to $14.00 and set a “buy” rating on the stock in a report on Wednesday, March 6th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, Enhabit presently has a consensus rating of “Hold” and an average target price of $12.08.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.